NP / PA
Liberty Medical Clinic
Liberty Medical Clinic was paid $681K by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoLIBERTY MEDICAL CLINIC
LIBERTY, KY 42539
LIBERTY, KY 42539
33aNPI1477844835assigned 04/20/2011
33bProvider typeFamily Nurse Practitioner
28Total paid$681K
24GClaims35,407
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Kentucky
Rank by total paid#34 of 424
Median peer was paid$19K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,828 | $137K | |
| 2019 | 6,573 | $127K | |
| 2020 | 4,197 | $85K | |
| 2021 | 5,455 | $64K | |
| 2022 | 3,696 | $81K | |
| 2023 | 3,142 | $101K | |
| 2024incomplete | 4,516 | $86K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 12,745 | 7,674 | $299K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 6,685 | 5,046 | $208K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.8% | 969 | 843 | $53K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.5% | 3,028 | 1,786 | $24K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.4% | 330 | 282 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 384 | 311 | $15K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 326 | 272 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 726 | 357 | $9K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 121 | 104 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 571 | 497 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 778 | 616 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 115 | 101 | $4K |
36 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 1,778 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 242 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 220 | $2K |
| 90688 | <1% | 226 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 32 | $1K |
| 90674 | <1% | 68 | $1K | |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | <1% | 206 | $986.39 |
| 87634 | <1% | 16 | $725.31 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $389.19 |
| 82043 | <1% | 66 | $252.83 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 225 | $245.10 |
| 90756 | <1% | 17 | $232.54 | |
| G0008 | Administration of influenza virus vaccine | <1% | 77 | $179.90 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 21 | $169.80 |
| 81003 | <1% | 482 | $165.44 | |
| 90686 | <1% | 21 | $160.41 | |
| 90658 | <1% | 16 | $156.83 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 20 | $156.61 |
| 99000 | <1% | 2,422 | $151.61 | |
| 90473 | <1% | 12 | $92.55 | |
| 1159F | 0% | 417 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 436 | $0.00 |
| 1124F | 0% | 131 | $0.00 | |
| 90633 | 0% | 68 | $0.00 | |
| 1160F | 0% | 419 | $0.00 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 23 | $0.00 |
| 90461 | 0% | 44 | $0.00 | |
| 1158F | 0% | 101 | $0.00 | |
| 90649 | 0% | 16 | $0.00 | |
| 3078F | 0% | 17 | $0.00 | |
| 1170F | 0% | 328 | $0.00 | |
| 1125F | 0% | 151 | $0.00 | |
| 1126F | 0% | 228 | $0.00 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 0% | 21 | $0.00 |
| 3074F | 0% | 36 | $0.00 | |
| 90716 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARPLE, VICKIE (NURSE PRACTITIONER/OWNER)